Cargando…
Neuroprotection in Glaucoma: NAD(+)/NADH Redox State as a Potential Biomarker and Therapeutic Target
Glaucoma is the leading cause of irreversible blindness worldwide. Its prevalence and incidence increase exponentially with age and the level of intraocular pressure (IOP). IOP reduction is currently the only therapeutic modality shown to slow glaucoma progression. However, patients still lose visio...
Autores principales: | Petriti, Bledi, Williams, Pete A., Lascaratos, Gerassimos, Chau, Kai-Yin, Garway-Heath, David F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226607/ https://www.ncbi.nlm.nih.gov/pubmed/34198948 http://dx.doi.org/10.3390/cells10061402 |
Ejemplares similares
-
The Role of Mitophagy in Glaucomatous Neurodegeneration
por: Stavropoulos, Dimitrios, et al.
Publicado: (2023) -
Mitochondrial NAD(+)/NADH Redox State and Diabetic Cardiomyopathy
por: Berthiaume, Jessica M., et al.
Publicado: (2019) -
NADH/NAD(+) Redox Imbalance and Diabetic Kidney Disease
por: Yan, Liang-Jun
Publicado: (2021) -
Rapamycin maintains NAD(+)/NADH redox homeostasis in muscle cells
por: Zhang, Zhigang, et al.
Publicado: (2020) -
Assessment of NADH/NAD(+) Redox Imbalance in Psoriatic Lesions Using the FMSF Technique: Therapeutic Aspects
por: Gebicki, Jerzy, et al.
Publicado: (2023)